Fayil:Pulmonary and cardiovascular dysfunction and their cellular basis.png
Yanayin wannan rigayi gani: 800 × 463 pixels. Wasu yarjejeniyoyi: 320 × 185 pixels | 640 × 370 pixels | 1,024 × 592 pixels | 1,280 × 741 pixels | 2,560 × 1,481 pixels | 3,664 × 2,120 pixels.
Hoton asali (pikisal 3,664 × 2,120, girman fayil: 812 KB, irin MIME: image/png)
Tarihin fayil
Ku latsa rana/lokaci ku ga fayil yadda yake a wannan lokaci
Rana/Lokaci | Wadar sufa | Kusurwowi | Ma'aikaci | Bahasi | |
---|---|---|---|---|---|
na yanzu | 10:09, 26 ga Faburairu, 2024 | 3,664 × 2,120 (812 KB) | Ameisenigel | {{Information |Description=Summary of pulmonary and cardiovascular dysfunction and their cellular basis. (a) EC use has been linked to disease and dysfunction in the heart and lungs. (b) i. Platelets are activated towards a pro-thrombotic phenotype in the vessel; ii. ECA exposure promotes endothelial cell death and compromised barrier function, which facilitates immune cell extravasation into the surrounding tissue. Endothelial cells release inflammatory cytokines that enhance neutrophil recr... |
Amfani da fayil
Wadannan shafi na amfani wannan fayil: